As reported, after the procedure, during the follow-up examination of the patient, the doctor noted that the stent had a fracture in its structure.There was no report of patient injury.The device is still implanted in the patient.The device is not available for analysis.
|
A report was received that the stent of a 6 x 40mm 135cm precise pro rx carotid system fractured sometime after having been implanted.There was no report of patient injury.Attempts to obtain images and/or films of the index or subsequent procedures and to obtain further information about this event have been unsuccessful.The device remains implanted in the patient and is thus not available for return to the manufacturer.A review of the manufacturing records for this lot of products revealed that it met specification prior to release.Without the return of the device for analysis or films of the event, the reported customer complaint could not be confirmed and no determination of possible contributing factors could be made.The instructions for use (ifu) directs users to perform an arterial angiogram to verify full deployment of the stent.If incomplete stent expansion exists, post-deployment dilatation can be performed at the discretion of the physician.The clinical implications of stent fractures are not well characterized.Nitinol fatigue leading to stent fractures is a well-known and documented intermediate and long term issues in the distal sfa.Deployment of stents in these types of lesions present multiple forces at work including flexion, torsion, longitudinal expansion and contraction.Based on the limited information available for review, it is not possible to determine what factors may have contributed to the reported event.Based on the device history record review, there is no indication that the event was related to the manufacturing process.Therefore, no corrective actions will be taken at this time.
|